1,095
Views
28
CrossRef citations to date
0
Altmetric
Review

Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug–microbiome interactions

ORCID Icon, , , &
Pages 1043-1055 | Received 04 Jul 2018, Accepted 26 Sep 2018, Published online: 09 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Moamen M. Elmassry, Ahmed Zayed & Mohamed A. Farag. (2022) Gut homeostasis and microbiota under attack: impact of the different types of food contaminants on gut health. Critical Reviews in Food Science and Nutrition 62:3, pages 738-763.
Read now
Ramón Cacabelos, Natalia Cacabelos & Juan C. Carril. (2019) The role of pharmacogenomics in adverse drug reactions. Expert Review of Clinical Pharmacology 12:5, pages 407-442.
Read now

Articles from other publishers (26)

Hassan Shokri Garjan, Yadollah Omidi, Mehdi Poursheikhali Asghari & Reza Ferdousi. (2023) In-silico computational approaches to study microbiota impacts on diseases and pharmacotherapy. Gut Pathogens 15:1.
Crossref
Jinping Zhou, Rui Zhang, Pengpeng Guo, Peixia Li, Xixi Huang, Ye Wei, Chunxiao Yang, Jiali Zhou, Tingyu Yang, Yani Liu & Shaojun Shi. (2022) Effects of intestinal microbiota on pharmacokinetics of cyclosporine a in rats. Frontiers in Microbiology 13.
Crossref
Amir Hossein Miri, Mojtaba Kamankesh, Antoni Llopis-Lorente, Chenguang Liu, Matthias G. Wacker, Ismaeil Haririan, Hamid Asadzadeh Aghdaei, Michael R. Hamblin, Abbas Yadegar, Mazda Rad-Malekshahi & Mohammad Reza Zali. (2022) The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications. Frontiers in Pharmacology 13.
Crossref
C. K. Nkera-Gutabara, R. Kerr, J. Scholefield, S. Hazelhurst & J. Naidoo. (2022) Microbiomics: The Next Pillar of Precision Medicine and Its Role in African Healthcare. Frontiers in Genetics 13.
Crossref
Pooja Dhurjad, Chinmayi Dhavaliker, Kajal Gupta & Rajesh Sonti. (2022) Exploring Drug Metabolism by the Gut Microbiota: Modes of Metabolism and Experimental Approaches. Drug Metabolism and Disposition 50:3, pages 224-234.
Crossref
Peter J.M. Clements, Brad Bolon, Elizabeth McInnes, Sydney Mukaratirwa & Cheryl Scudamore. 2022. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology 653 694 .
Ana Bačić & Mirjana Rajilić-Stojanović. 2022. Comprehensive Gut Microbiota. Comprehensive Gut Microbiota 1 12 .
Faiza Abdur Rab & Azizul Hassan. 2022. Handbook of Technology Application in Tourism in Asia. Handbook of Technology Application in Tourism in Asia 1159 1200 .
Ibrahim E. Sallam, Amr Abdelwareth, Heba Attia, Ramy K. Aziz, Masun Nabhan Homsi, Martin von Bergen & Mohamed A. Farag. (2021) Effect of Gut Microbiota Biotransformation on Dietary Tannins and Human Health Implications. Microorganisms 9:5, pages 965.
Crossref
Moamen M. Elmassry, Sunghwan Kim & Ben Busby. (2021) Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes. PLOS ONE 16:1, pages e0244876.
Crossref
Jiayu Sun, Fuya Zhao, Baiqiang Lin, Jing Feng, Xin Wu, Yang Liu, Lei Zhao, Biqiang Zhu & Yunwei Wei. (2020) Gut Microbiota Participates in Antithyroid Drug Induced Liver Injury Through the Lipopolysaccharide Related Signaling Pathway. Frontiers in Pharmacology 11.
Crossref
Susanne B Haga. (2020) Individualizing pharmacogenomic test results in the context of the microbiome. Personalized Medicine 17:6, pages 459-468.
Crossref
Ana López-Moreno, Antonio Suárez, Camila Avanzi, Mercedes Monteoliva-Sánchez & Margarita Aguilera. (2020) Probiotic Strains and Intervention Total Doses for Modulating Obesity-Related Microbiota Dysbiosis: A Systematic Review and Meta-analysis. Nutrients 12:7, pages 1921.
Crossref
Alice Rouanet, Selin Bolca, Audrey Bru, Ingmar Claes, Helene Cvejic, Haymen Girgis, Ashton Harper, Sidonie N. Lavergne, Sophie Mathys, Marco Pane, Bruno Pot, Colette Shortt, Wynand Alkema, Constance Bezulowsky, Stephanie Blanquet-Diot, Christophe Chassard, Sandrine P. Claus, Benjamin Hadida, Charlotte Hemmingsen, Cyrille Jeune, Björn Lindman, Garikai Midzi, Luca Mogna, Charlotta Movitz, Nail Nasir, Manfred Oberreither, Jos F. M. L. Seegers, Luc Sterkman, Audrey Valo, Frédérique Vieville & Magali Cordaillat-Simmons. (2020) Live Biotherapeutic Products, A Road Map for Safety Assessment. Frontiers in Medicine 7.
Crossref
Jose U. Scher, Renuka R. Nayak, Carles Ubeda, Peter J. Turnbaugh & Steven B. Abramson. (2020) Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response. Nature Reviews Rheumatology 16:5, pages 282-292.
Crossref
Nehal Adel Abdelsalam, Ahmed Tarek Ramadan, Marwa Tarek ElRakaiby & Ramy Karam Aziz. (2020) Toxicomicrobiomics: The Human Microbiome vs. Pharmaceutical, Dietary, and Environmental Xenobiotics. Frontiers in Pharmacology 11.
Crossref
Francesca Ferlenghi, Riccardo Castelli, Laura Scalvini, Carmine Giorgio, Miriam Corrado, Massimiliano Tognolini, Marco Mor, Alessio Lodola & Federica Vacondio. (2020) Drug-gut microbiota metabolic interactions: the case of UniPR1331, selective antagonist of the Eph-ephrin system, in mice. Journal of Pharmaceutical and Biomedical Analysis 180, pages 113067.
Crossref
Weihua Huang & Wei Zhang. 2020. Pharmacogenomics in Precision Medicine. Pharmacogenomics in Precision Medicine 181 199 .
Michael Coryell, Barbara A. Roggenbeck & Seth T. Walk. (2019) The Human Gut Microbiome’s Influence on Arsenic Toxicity. Current Pharmacology Reports 5:6, pages 491-504.
Crossref
Yalda Hekmatshoar, Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, Tulin Ozkan, Fatemeh Zununi Vahed, Ziba Nariman-Saleh-Fam, Bahram Pourghassem Gargari, Asuman Sunguroglu & Sepideh Zununi Vahed. (2019) The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?. Life Sciences 233, pages 116680.
Crossref
Nele Brusselaers. (2019) Prescribed Drugs and the Microbiome. Gastroenterology Clinics of North America 48:3, pages 331-342.
Crossref
Anukriti Sharma, Mary M. Buschmann & Jack A. Gilbert. (2019) Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?. Clinical Pharmacology & Therapeutics 106:2, pages 317-328.
Crossref
Michael Zimmermann, Maria Zimmermann-Kogadeeva, Rebekka Wegmann & Andrew L. Goodman. (2019) Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570:7762, pages 462-467.
Crossref
Sara A. Zahran, Marwa Ali-Tammam, Abdelgawad M. Hashem, Ramy K. Aziz & Amal E. Ali. (2019) Azoreductase activity of dye-decolorizing bacteria isolated from the human gut microbiota. Scientific Reports 9:1.
Crossref
Malavikalakshmi M. Attur & Jose U. Scher. 2019. Infections and the Rheumatic Diseases. Infections and the Rheumatic Diseases 11 19 .
Ramy K. Aziz. (2018) Toxicomicrobiomics: Narrowing the Gap Between Environmental and Medicinal Toxicogenomics. OMICS: A Journal of Integrative Biology 22:12, pages 788-789.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.